Myocarditis and Vaccines

Young people recover quickly from rare myocarditis side effect of COVID-19 vaccine Circulation Journal Report Research Highlights: Most adolescents and young adults with suspected myocarditis following a COVID-19 vaccination experience mild symptoms and rapid clinical recovery, though many had evidence of continued heart inflammation, according to a new study published today. Study authors said fast ventricular rhythms and the need for medications to increase blood pressure were uncommon; no patients died or needed mechanical support for circulation as a result of the condition. While cases of myocarditis following COVID-19 vaccinations continue to be rare, more research is needed to understand whether there are long-term cardiac effects of COVID-19-vaccine-associated myocarditis. Embargoed until 4 a.m. CT/5 a.m. ET Monday, Dec. 6, 2021 DALLAS, Dec. 6, 2021 — Most young...

A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products 10/07/2021 Web Internet Archive Capture Abstract Following the global rollout and administration of the Pfizer Inc./BioNTech BNT162b2 and Moderna mRNA-1273 vaccines on December 17, 2020, in the United States, and of the Janssen Ad26.COV2.S product on April 1st, 2021, in an unprecedented manner, hundreds of thousands of individuals have reported adverse events (AEs) using the Vaccine Adverse Events Reports System (VAERS). We used VAERS data to examine cardiac AEs, primarily myocarditis, reported following injection of the first or second dose of the COVID-19 injectable products. Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p

https://newsroom.heart.org/news/cdc-investigating-rare-myocarditis-in-teens-young-adults-covid-19-vaccine-still-advised-for-all-who-are-eligible CDC investigating rare myocarditis in teens, young adults; COVID-19 vaccine still advised for all who are eligible Statement from the American Heart Association/American Stroke Association Updated June 23, 2021 - HHS.gov - Statement Following CDC ACIP Meeting from Nation’s Leading Doctors, Nurses and Public Health Leaders on Benefits of Vaccination DALLAS, Saturday, June 12, 2021 – On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) alerted health care professionals that the COVID-19 Vaccine Safety Technical Work Group (VaST) of the CDC’s Advisory Committee on Immunization Practices (ACIP) is meeting during the June 23-25 ACIP meeting to review cases of myocarditis, a rare but serious inflammation of the heart, reported in adolescents and young adults after receiving a COVID-19 vaccine manufactured by Pfizer-BioNTech or M...

They say rare. "At Least 18 Cases of Apparent Heart Problems in Young People in CT After COVID-19 Vaccine" https://www.nbcconnecticut.com/news/coronavirus/connecticut-confirms-at-least-18-cases-of-apparent-heart-problems-in-young-people-after-covid-19-vaccination/2494534/?_osource=SocialFlowFB_CTBrand They CDC was said to be investigating it in May 2021. So how could the CDC say only 71 cases. We can see on NBC station alone a story mentioning 18. https://www.nbcconnecticut.com/news/coronavirus/covid-vaccine/mom-of-conn-teen-speaks-after-son-suffers-heart-condition-days-after-covid-19-vaccine/2495057/ "Gifford said all but one of the young adults hospitalized for signs of heart problems have been released. Four of those young residents were hospitalized at Yale New Haven Health and three at Connecticut Children's. Health officials say the reported cases appear to be mild and typically begin within four days after the second dose of the Pfizer and Moderna v...